Avid Radiopharmaceuticals: The Venture Debt Question Harvard Case Solution & Analysis

The CEO of a promising biotech company must decide the best way to respond to the macro-economic recession of late 2008. He had intended to pursue an belligerent agenda transferring the Alzheimer's and Parkinson's disease imaging compounds through clinical trials and into the market of the firm.

This involved expanding headcount and the firm's facilities and he planned to finance this by taking venture debt. Although clinical trial data is extremely encouraging, questions about raising the total environment and his next venture round has made him question the wisdom of this plan. This case provides the opportunity to explore the true price of venture debt and when it's used to reach the targets of all parties to students - venture capitalists, entrepreneurs, and enterprise lenders.

PUBLICATION DATE: December 08, 2009 PRODUCT #: 510C12-HCB-CHI

This is just an excerpt. This case is about LEADERSHIP & MANAGING PEOPLE

Avid Radiopharmaceuticals: The Venture Debt Question Case Solution Other Similar Case Solutions like

Avid Radiopharmaceuticals: The Venture Debt Question

Share This